Related Experiment Video
Updated: Sep 9, 2025

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
Prescriber Attitudes Towards Prescribing 'Green' Inhalers in Secondary Care
Aazaz Rehman1, Joseph Marchant1, Jiakun Yu2
1Respiratory Medicine, University Hospitals Sussex, Brighton, GBR.
None:
Introduction The climate emergency is advancing at a rapid rate and affecting every corner of the globe. Healthcare has been calculated to be responsible for a considerable part of global greenhouse gas (GHG) emissions. Dry powder inhalers (DPIs) are a lower-carbon alternative to pressurised metered dose inhalers (MDIs); however, many patients remain on MDIs. This study aimed to identify barriers to switching to DPIs, as a trust-wide audit of pressurised MDIs (pMDIs) revealed that very few of the patients eligible for a DPI were offered it in secondary care, despite sustainability initiatives. Methods We conducted interviews focusing on the perceptions and experiences of secondary care healthcare professionals (HCPs) relating to inhaler prescribing. Potential participants were selected through purposive sampling to ensure a broad perspective. Semi-structured interviews were conducted, and their transcripts were coded using QSR NVivo (Burlington, MA). Qualitative data were organised and analysed thematically using the framework method. Results Nineteen participants were recruited from varying grades and disciplines within secondary care. Three themes relating to attitudes towards sustainable inhaler prescribing emerged: 1) the awareness of suitable inhalers, 2) knowledge and 3) making an impact. Conclusion HCPs indicated a desire to reduce the carbon footprint generated by healthcare. However, the poor awareness of the inhaler carbon footprint acted as a barrier to promote sustainable inhaler prescribing. Where participants were aware of their carbon footprint, a lack of knowledge and confidence regarding inhalers prevented a change to sustainable inhalers. Overall, this study shows that existing sustainability initiatives are not delivering the intended impact and that more work is required around raising awareness and education regarding inhalers.
Related Concept Videos
Inhaled Medications
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-IV: Nursing Management
First, in...

